SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-073199
Filing Date
2024-06-13
Accepted
2024-06-13 18:19:36
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4029
  Complete submission text file 0000950170-24-073199.txt   5598
Mailing Address C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Gallagher Brian M. Jr. (Reporting) CIK: 0001709976 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39866 | Film No.: 241042502

Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)